Humans may be exposed to 2-aminoanthracen e (2-AA), a substituted polycyclic aromatic hydrocarbon , and a recognized mutagen and carcinogen , through oral and respiratory routes from contact with a variety of environmenta l sources. For the present study, we sought to evaluate hepatic damage and recovery in Fischer 344 rats following multiple IP injections of 5 mg of 2-AA. Rats were injected weekly for up to 5 weeks. Subgroups were then allowed to recover for 1, 5, or 9 weeks, and biochemical and pathologic changes were evaluated. We observed that weight gains were reduced relative to controls for all groups receiving 2 injections. Serum enzyme levels indicative of liver damage were evident and included alterations in serum aspartate aminotransferase, alkaline phosphatase, total protein, albumin, and globulin. These alterations usually returned to normal by 5 weeks following cessation of 2-AA administration. In contrast, histologic liver changes, including hepatocyt e hypertroph y, biliary hyperplasia with oval cell proliferation, altered foci, nodular hyperplasia, and one hepatocellular adenoma became more severe with time. This experiment demonstrates patterns of hepatic damage and recovery in rats exposed to 2-AA.
INTRODUCTION
The arylamines are a class of polycyclic aromatic hydrocarbons synthesized for a variety of industrial purposes and produced naturally during the burning of tobacco and the broiling of meat (18, 23) . Human exposure therefore results from a variety of occupational and nonoccupational sources and has been associated with the occurrence of bladder cancer (22) . Compounds in this class are known to undergo metabolic activation, primarily in the liver (19) . Activation involves N -hydroxylation (9, 25) , while detoxi cation involves N -acetylation (10) . N-hydroxy arylamines may be conjugated by glucuronidation (8) and excreted in the bile. Additionally, O-acetylation in the colon can further activate N -hydroxy metabolites (10) . Thus, the effects of these compounds on liver and other organs is of concern. In this regard, the aromatic amines are known to induce tumors at a number of sites in experimental animals including the liver, mammary gland, intestine, and lung (1, 6, 21, 26) .
In the rat liver, early changes caused by arylamine toxicity have been shown to precede the development of enzymealtered foci (13) and include an increase in the number of cells undergoing apoptosis, followed by an increase in proliferation rate (2) . Under certain experimental conditions, a balance may be reached between adaptation and stress response (2) . Also, there is a decrease in arylamine activating capacity in livers with preneoplastic (hyperplastic) nodules, likely due to selective decrease in hepatic content of speci c P-450 isozymes (14) . Similarly, an increased rate of devel-opment of aberrant crypt foci have been observed in colons from rapid acetylator strains of rats, such as the Fischer-344, versus tissues from slow acetylator phenotypes (7) .
The arylamine 2-aminoanthracene (2-AA), which occurs in cigarette smoke, cooked meats, as a component of road tar, and in fractions obtained from oil re ning, is an ideal compound with which to study the metabolism and toxic effects of this important class of chemicals, because it is an environmental agent to which humans may be exposed by both dietary and inhalation routes. Furthermore, it is both a direct-acting carcinogen in animal models (15) and an inducer of mutations in eukaryotic (16) , and prokaryotic (11) cells.
The present study is part of a series of experiments seeking to identify the toxicologic effects of speci c chemicals associated with energy production. The objectives of the present study were to evaluate pathologic changes occurring following IP exposure to 2-AA and to determine if any resulting lesions, both clinicopathologic and histologic, were reversible on discontinuation of compound administration. Both questions are relevant to potential human exposures.
MATERIALS AND METHODS

Animals and Animal Husbandry
Male F-344 rats were used in this study. Rats were housed in an Association for the Assessment and Accreditation of Laboratory Animal Care, International (AAALAC)accredited facility. Rats were fed commercial rodent chow (Lab Diet 5001; PMI Nutrition International, Inc, Brentwood, Missouri) and provided tap water ad libitum. Rats were housed on 1/8-inch "Bed-O-Cobs" (The Andersons Industrial Products Group, Maumee, Ohio) in polycarbonate shoebox cages with 11 air changes per hour and a 12:12 hr 328 0192-6233/01$3.00 $0.00 light:dark cycle. Sentinel rats were negative for antibodies to common rat pathogens, including pneumonia virus of mice, sendai virus, sialodacryoadenitis virus, Kilham's rat virus, and Mycoplasma pulmonis. The study was approved by the Institutional Animal Care and Use Committee, and the Chemical Safety Committee.
Compound Administration
The 2-AA used in the study was purchased from Aldrich Chemical Co. (catalog #A3,880-0; Aldrich Chemical Co, Milwaukee, WI). The 2-AA was dissolved in DMSO (catalog #D-8779; Sigma Chemical Co, St. Louis, MO), followed by the addition of an equal volume of deionized water. The suspension was thoroughly mixed prior to injection.
Experimental Design
Fifteen groups of 5 rats each, and 15 companion control groups of 2 rats each (total 105 rats) were used in this experiment. Rats were 40-46 days of age (mean 43.7 days), and weighed 92-195 g (mean 127.9 g). Groups of rats were injected weekly for 1-5 weeks IP with either 2-AA (5 mg/rat/week) or vehicle (1:1 DMSO:H 2 O), and were euthanized 1, 5, or 9 weeks after the last injection. During CO 2 euthanasia, blood was collected via cardiocentesis. Following euthanasia, rats were necropsied. Abdominal organs were preserved in 10% neutral buffered formalin and processed routinely for histologic examination. Percent change in body and liver weights, as percentages of body weight; and gross and microscopic lesions were compared using injection with 2-AA versus vehicle as variables. Additionally, select serum chemistry values, including serum glucose, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total protein, albumin, globulin, bilirubin, and alkaline phosphatase (AP) were evaluated (Olympus AU600 Chemistry Immuno-Analyzer; Olympus America Inc, Melville, New York) and compared between groups using injection with 2-AA versus vehicle, number of injections, and recovery period as variables.
Ten additional 14-to 15-week-old, conventionally housed, male F344 rats were euthanized via CO 2 , and had blood collected terminally by cardiocentesis. Serum was separated and submitted for clinical chemistry pro les similar to those of experimental rats described previously. Clinical chemistry values from these animals served as normal reference data.
Statistical Analyses
Statistical analyses were performed using dedicated statistical software (Number Cruncher Statistical Systems, Dr J. L. Hintze, Kaysville, UT). Clinical chemistry values were ranked for each variable, and group effect was determined by Kruskal-Wallis 1-way ANOVA on ranks. When overall group effect was found for any variable, values were reranked to determine group effects for 2-AA versus DMSO, number of injections of 2-AA and DMSO, and weeks until recovery for 2-AA and DMSO, with Fisher's Least Signi cant Differences Test used as a post hoc test to allow pair-wise comparisons of groups. Also, 1-way ANOVA was used to compare clinical chemistry values obtained from 2-AA treated or DMSO treated rats, with those from normal reference animals. For all analyses, signi cance was set at p < 0.05.
RESULTS
Overall, most rats appeared clinically normal throughout the course of the study. Weight gains were reduced relative to controls for all groups receiving 2 injections, 3 or 4 injections, or 2 injections for groups recovered 1, 5, or 9 weeks, respectively. Liver weights did not differ between groups given 2-AA and their respective controls. However, liver weight as a percentage of body weight was greater in rats receiving 3 injections and recovering 1 or 5 weeks vs controls.
Two rats died of injection-related complications within 48 hours of the rst injection, and were replaced. Three rats died or were humanely euthanized in a moribund condition 4 to 5 days after their fth injections of 2-AA. At necropsy, 22 rats that had received multiple injections of 2-AA had enlarged livers with rounded borders, and 8 rats receiving 4 to 5 injections of 2-AA had spots, approximately 5 mm in diameter, of what appeared to be 2-AA deposits on their abdominal viscera.
Numbers and types of induced lesions in the various experimental groups are shown in Table 1 . The mildest lesion attributed to treatment with 2-AA was hepatocytic hypertrophy, consisting of dense eosinophilic expanded cytoplasm. This change occurred predominantly in periportal regions, but extended at times to midzonal and even centrilobular areas of the affected lobules. This change varied among lobules in a tissue section and among liver sections in a rat. Hyperplasia and increased numbers in periportal biliary ductules were seen as a mild change, typically localized to a small portion of a liver section, and were occasionally surrounded by slightly hyperchromatic oval cells with open nuclei and little, if any, cytoplasm. Biliary hyperplasia with or without early slight brosis and with or without oval cell proliferation, accentuated the normal lobular outlines in affected areas. Altered hepatic foci consisted of discrete nodules of hepatocytes that displaced normal parenchyma. They appeared as clear cell foci, composed of vacuolated hepatocytes, or as eosinophilic foci, composed of dense eosinophilic hepatocytes, or as mixed foci consisting of both. Nodular hyperplasia presented as isolated nodules of proliferated hepatocytes had discrete borders and lacked normal lobular architecture. These were accompanied by surrounding early periportal biliary hyperplasia and brosis. A single hepatocytic adenoma (hepatoma) was seen in 1 treated rat. This consisted of eosinophilic hepatocytes that grew in a discrete, well-delineated nodule that displaced and compressed surrounding parenchyma.
Degenerative changes in pancreatic islets consisted of cytoplasmic vacuolation with decreased numbers of cells, or of areas of cellular loss with empty spaces remaining. In addition, lesions were seen that were considered incidental to treatment. Granulomatous peritonitis with brosis and crystal-containing granulomas was seen in multiple-injected principal rats. This lesion involved the liver capsule and peripancreatic fat and was considered to be a direct effect of the IP injections. Varying degrees of hydronephrosis, both unilateral and bilateral, were seen in the experimental rats. These were not correlated with treatment and were considered to be independent of the treatment protocol.
There were no group effects for serum glucose, ALT, and bilirubin levels. In contrast, altered serum concentrations of AST, AP, total protein, albumin, globulin, blood urea nitrogen, and creatinine were found in animals administered 2-AA. Effects on the latter serum chemistry values are presented in Table 2. DISCUSSION Previous studies by this research group on the effects of 2-AA administered daily to Fischer 344 rats fed a balanced, powdered, control diet revealed that hepatic lesions were evident by 14 days of exposure to 2-AA when fed at 0.01% of diet by weight. Less severe lesions were evident in rats fed 0.005% and 0.0075% 2-AA (3). Pilot studies revealed that study and has not been previously reported in any other 2-AA toxicity study. In this experiment, weight gain changes affected by 2-AA administration were recovered with time. Consistent with our dietary studies, liver weight as a percentage of body weight usually did not differ with 2-AA exposure. Exceptions to this nding were limited to two groups with relatively short recovery periods, again suggesting recovery of body weight with time.
In contrast, liver lesions progressed from hepatocellular hypertrophy, to modular hyperplasia, and on to altered foci. These changes formed a continuum of severity of liver injury. Clear-cell foci and mixed foci are generally considered to be preneoplastic, and 1 hepatocellular adenoma was diagnosed in the 5-treatment-9 week-interval group of rats. Given additional time, it is reasonable to assume that additional tumors would have developed.
Clinicopathologic changes induced by 2-AA were generally similar to those noted previously by this research group when rats were chronically fed 2-AA for 30 days (3) . In the present study, serum glucose, ALT, and bilirubin levels were not affected by IP 2-AA administration at the dosages examined. In contrast, altered serum concentrations of AST, AP, total protein, albumin, and globulin were observed in animals administered IP 2-AA and were associated with liver pathology. In many instances, analyte levels had essentially returned to normal after 5 weeks of recovery. This is exempli ed by comparing globulin levels from rats injected 5 times, and recovered 1, 5, and 9 weeks and is shown in Figure 1 . Little additional recovery occurred between 5 and 9 weeks. From these data, we concluded that the liver had essentially recovered biochemically after 5 weeks post-IP 2-AA administration.
Consistent with other forms of liver injury, although histologic lesions in the livers tended to be more common and severe with longer recovery periods, it was of interest that clinical chemistry values generally returned to normal within 5 weeks of the nal 2-AA injection. These ndings suggest that although hepatocellular recovery occurred relatively rapidly, subcellular changes (such as DNA mutations) may have occurred that did not become phenotypically evident until the liver cells had gone through several cycles of replication. This conclusion is generally compatible with the ndings of others. For example, the rat-CCl 4 model is wellestablished for studies of hepatic injury and repair (4, 17, 24) . In one study, serum enzyme levels, but not histopathologic alterations, returned to normal within 13 days of cessation of exposure (4) . In contrast, Wang and coworkers found that both serum ALT and AST activities, as well as severity of liver lesions, were maximal 24 hours after CCl 4 exposure (24). Rao et al (17) assessed liver injury and repair out to 4 days in male Sprague-Dawley rats injected with a dose range of CCl 4 , and reported that at low doses, tissue repair increased in a dose-dependent manner until a threshold was reached, beyond which tissue repair was signi cantly delayed, diminished, and overwhelmed by tissue injury (17) .
A considerable amount of literature is available concerning hepatic recovery following exposure to other toxic compounds. However, most studies evaluated repair over relatively short periods (generally less than 1 week) in which the regeneration response is measured at the subcellular level by ( 3 H)thymidine incorporation into hepatocellular DNA (20) or by expression of proliferating cell nuclear antigen (12) , which occurs within 24 to 48 hours of injury. However, it is also important to evaluate longer-term recovery, at both the cellular and tissue level. We therefore chose to evaluate serum chemistry and histologic recovery as indicators of hepatic functional capability. Our ndings indicate that histological evidence suggestive of subcellular injury most likely did occur. We have yet to directly demonstrate genetic alterations, however. In future experiments it will be important to evaluate whether mutations are induced, and if so, whether DNA repair is occurring. Also, while several models have been developed to study hepatocellular repair following toxic injury, yet differences appear to exist in mechanisms of repair. Response to some compounds involves activation of putative progenitor cells that proliferate and differentiate, putatively, to hepatocytes and to biliary epithelium. These oval cells were seen in higher dose, longer-lived rats in this study, in some instances in large proportions. The more typical form of hepatocytic regeneration is through proliferation of differentiated mature hepatocytes (5) . Future experiments will seek to determine both the mechanisms of tissue damage and mechanisms of repair, and will, taken together, offer insight into mechanisms that occur following human exposure to these compounds.
